(Q54440177)

29 May 2018

review article

1 reference

title

Role of GnRH drive in the pathophysiology of polycystic ovary syndrome. (English)

1 reference

29 May 2018

polycystic ovary syndrome

main subject

1 reference

1 reference

1 reference

M P Leondires

1

1 reference

29 May 2018

S L Berga

series ordinal

2

1 reference

29 May 2018

publication date

1 July 1998

1 reference

29 May 2018

Journal of Endocrinological Investigation

published in

1 reference

29 May 2018

volume

21

1 reference

29 May 2018

issue

7

1 reference

29 May 2018

page(s)

476-485

1 reference

29 May 2018

https://scigraph.springernature.com/pub.10.1007/bf03347331

exact match

0 references

cites work

Polycystic ovaries--a common finding in normal women

1 reference

https://api.crossref.org/works/10.1007%2FBF03347331

Polycystic ovary syndrome: a changing perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347331

Acanthosis nigricans in obese women with hyperandrogenism. Characterization of an insulin-resistant state distinct from the type A and B syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347331

Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347331

Insulin resistance--mechanisms, syndromes, and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347331

Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347331

Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347331

The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347331

Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347331

The influence of body weight on lipoprotein lipids in patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347331

Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347331

Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347331

Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347331

Inappropriate Secretion of Follicle-Stimulating Hormone and Luteinizing Hormone in Polycystic Ovarian Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347331

Control of the rhesus monkey menstrual cycle: permissive role of hypothalamic gonadotropin-releasing hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347331

Differential control of luteinizing hormone and follicle-stimulating hormone secretion by luteinizing hormone-releasing hormone pulse frequency in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347331

Reduction of gonadotropin-releasing hormone pulse frequency is associated with subsequent selective follicle-stimulating hormone secretion in women with polycystic ovarian disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347331

A striking sex difference in the gonadotropin response to gonadectomy during infantile development in the rhesus monkey (Macaca mulatta).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347331

A chronobiologic abnormality in luteinizing hormone secretion in teenage girls with the polycystic-ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347331

The effect of bromocriptine on gonadotropin and steroid secretion in polycystic ovarian disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347331

Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347331

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347331

Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347331

Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347331

Opioidergic regulation of LH pulsatility in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347331

Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347331

Serum leptin concentrations in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347331

Circulating leptin concentrations in polycystic ovary syndrome: relation to anthropometric and metabolic parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347331

Insulin, neuropeptide Y, and food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347331

Neuropeptide Y. A novel sympathetic stress hormone and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347331

Control of luteinizing hormone-releasing hormone pulse generation in nonhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347331

Hypersecretion of luteinizing hormone and the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347331

Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin.

21 January 2018

1 reference

12 December 2020

Human female phenotypic development: role of fetal ovaries

1 reference

12 December 2020

Polycystic ovary syndrome

1 reference

12 December 2020

Is the inappropriate gonadotropin secretion of patients with polycystic ovary syndrome similar to that of patients with adult-onset congenital adrenal hyperplasia?

1 reference

12 December 2020

Steroid Biosynthesis by Isolated Human Ovarian Follicular Cells in Vitro*

1 reference

12 December 2020

Serum leptin levels in women with polycystic ovary syndrome: the role of insulin resistance/hyperinsulinemia

1 reference

12 December 2020

Increased luteinizing hormone and alpha-subunit secretion in women with hyperandrogenic anovulation

1 reference

12 December 2020

Luteinizing hormone: its role, mechanism of action, and detrimental effects when hypersecreted during the follicular phase

1 reference

12 December 2020

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

1 reference

12 December 2020

Pituitary function is altered during the same cycle in women with polycystic ovary syndrome treated with continuous or cyclic oral contraceptives or a gonadotropin-releasing hormone agonist.

1 reference

12 December 2020

Optimal use of hormone determinations in the biochemical diagnosis of the polycystic ovary syndrome.

1 reference

12 December 2020

A double blind controlled study of the hormonal and clinical effects of bromocriptine in the polycystic ovary syndrome

1 reference

12 December 2020

Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone

1 reference

12 December 2020

A prospective study of the prevalence of clear-cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopecia

1 reference

12 December 2020

Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization.

1 reference

12 December 2020

Resistance of gonadotropin releasing hormone drive to sex steroid-induced suppression in hyperandrogenic anovulation.

1 reference

12 December 2020

Clinical review 73: Medical treatment of androgen-dependent hirsutism.

1 reference

12 December 2020

Hypothalamic site-dependent effects of neuropeptide Y on gonadotropin-releasing hormone secretion in rhesus macaques

1 reference

12 December 2020

Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome

1 reference

12 December 2020

Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome

1 reference

12 December 2020

Neuropeptide Y in hypothalamic paraventricular nucleus: a center coordinating energy metabolism

1 reference

12 December 2020

Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome

1 reference

12 December 2020

Leptin concentrations in the polycystic ovary syndrome

1 reference

12 December 2020

The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome.

1 reference

12 December 2020

Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders

1 reference

12 December 2020

The precursors of endometrial carcinoma

1 reference

12 December 2020

Insulin resistance, hypersecretion of LH, and a dual-defect hypothesis for the pathogenesis of polycystic ovary syndrome

1 reference

12 December 2020

Surgically induced ovulation in the polycystic ovary syndrome: wedge resection revisited in the age of laparoscopy.

1 reference

12 December 2020

Congenital adrenal hyperplasia

1 reference

12 December 2020

Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome

1 reference

12 December 2020

Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients

1 reference

12 December 2020

Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women.

1 reference

12 December 2020

Hormonal effects of flutamide in young women with polycystic ovary syndrome

1 reference

12 December 2020

Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women

1 reference

12 December 2020

Androgen Biosynthesis in Human Ovarian Follicles: Cellular Source, Gonadotropic Control, and Adenosine 3′,5′ Monophosphate Mediation*

1 reference

12 December 2020

Circadian variations of luteinizing hormone can have two different profiles in adolescent anovulation

1 reference

12 December 2020

Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features

1 reference

12 December 2020

Ovulatory disorders in women with polycystic ovary syndrome

1 reference

12 December 2020

Metabolic effects of oral contraceptives in women with polycystic ovary syndrome

1 reference

12 December 2020

Comparison of luteinizing hormone pulsatility in the serum of women suffering from polycystic ovarian disease using a bioassay and five different immunoassays

1 reference

12 December 2020

Impact of obesity on insulin action in volunteers with normal glucose tolerance: demonstration of a threshold for the adverse effect of obesity

1 reference

12 December 2020

Effects of increasing the frequency of low doses of gonadotropin-releasing hormone (GnRH) on gonadotropin secretion in GnRH-deficient men

1 reference

12 December 2020

The ovarian contribution to peripherally derived serum C19 conjugates

1 reference

12 December 2020

Treatment of anovulation with pulsatile gonadotropin-releasing hormone: prognostic factors and clinical results in 600 cycles

1 reference

12 December 2020

Circulating luteinizing hormone pulse frequency in women with polycystic ovary syndrome

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03347331

1 reference

29 May 2018

1 reference

29 May 2018